Why the study?
Septic embolization is a common, life-threatening complication of infective endocarditis, and acute coronary syndrome secondary to septic embolism poses significant risks but remains rare.
Does coronary embolism affect mortality and cerebral embolism rates in patients with left-sided infective endocarditis?
Does coronary embolism affect mortality and cerebral embolism rates in patients with left-sided infective endocarditis?
Coronary embolism is a rare (1.2%) complication of left-sided infective endocarditis that is strongly associated with concurrent cerebral embolism, though it did not significantly impact overall mortality in this cohort.
BACKGROUND: Septic embolization is a common and potentially life-threatening complication of infective endocarditis (IE), with a prevalence of 22-50%. While acute coronary syndrome secondary to septic embolism is rare, it poses significant risks. AIMS: This study examines coronary embolism (CE) in left-sided IE, describing clinical characteristics and outcomes. METHODS: We retrospectively analysed 649 patients with non-device-related left-sided IE treated between January 2013 and December 2023 in a high-volume surgical centre. CE was diagnosed via ECG, clinical and laboratory signs of acute coronary syndrome, and confirmed by coronary angiography or magnetic resonance imaging. All patients were treated according to current European Society of Cardiology guidelines. A structured follow-up was performed. RESULTS: Among patients included in the study, surgery was performed in 514 (79%) patients. Median follow-up duration was 4.7 years. CE occurred in 8 (1.2%) patients, and 6 (80%) of them were treated surgically. We found no significant differences in overall mortality rate between patients with or without CE (p = 0.65). Finally, cerebral embolism was significantly more frequent in patients with than without CE (75% vs 25%, p = 0.006, post-hoc power 87.8%). CONCLUSION: CE is a rare but severe complication of IE, significantly associated with cerebral embolism. Early recognition and treatment are crucial to improve patient outcomes. Multicentre studies with larger patient populations are needed to further elucidate risk factors and enhance prognosis for CE in IE patients.
No takes yet. Share an insight, caveat, or question.
Mazzotta et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: